ALNYLAM PHARMACEUTICALS, INC. Deferred Income Tax Assets, Net
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Deferred Income Tax Assets, Net of $113.79 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-07-30
- 2026-06-30: Deferred Income Tax Assets, Net $113.79M.
- 2025-12-31: Deferred Income Tax Assets, Net $125.97M.
- 2025-09-30: Deferred Income Tax Assets, Net $98.56M.
- 2025-06-30: Deferred Income Tax Assets, Net $104.36M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $113.79M 10-Q · filed 2026-07-30 |
| 2025-12-31 | $125.97M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $98.56M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $104.36M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $107.22M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $116.86M 10-K · filed 2026-02-12 |
| 2023-12-31 | $10.10M 10-K · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |